Ebola Vaccine proves effective against Zaire strain

Usually most of the daily news is bad but today we woke up to very good news.  rVSV-ZEBOV, a recombinant, replication competent vesicular stomatitis virus-based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus has completed phase 1 human trials in Guinea, West Africa.  Vaccine efficacy was 100%  Fast track this one please (Merck has 300,000 doses ready in case of an outbreak).  We are highly impressed by this work and hope it will serve as a model for the future of rapid drug development and deployment in response to emerging epidemics.   

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)32621-6/fulltext

blog of interest

With final exams looming large I am not updating this blog too much right now -  I recommend checking out Jean Peccoud's blog here. I'll be back😸.

Women Scientists speak out against ignorance in high places

https://500womenscientists.org/#our-pledge

It came from outer space

https://arxiv.org/pdf/1611.07516v1.pdf

CRISPR-cas9 gene editing vs metastatic non-small-cell lung cancer

Yes, in humans.  

http://www.nature.com/news/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988

If successful, this could be a major development in a model of therapy for curing many diseases.

San Francisco Bay Area teachers - free equipment and supplies 4 U

This Saturday

http://biolinkdepot.org/index.php/get-supplies/open-house-dates/

Collaboration with Microbes

Collaboration with Microbes Nov 5, 2016 9:30 AM West Coast time.

This full-day conference will explore fermented food and drink, our microbial commons, how fermentation might heal our planet, and microbes that could heal our body.

Tickets to attend 

DG717 Coworking / Incubation Center

717 Market Street

Suite 100

San Francisco, CA 94103

Stream it here